fda warning bpc-157 peptide unapproved drug panel narrowly backs touted by Joe Rogan fda bpc-157 warning not approved

Specifically, the relatively small sample size, the unbalanced male/female ratio (with a higher number of males in two of the three cohorts), and the short intervention period constrained our ability to assess the long-term effects of the Sucrosomial B12 formulation

Simponi (golimumab) for ulcerative colitis Golimumab (brand name Simponi) is an injectable biologic medication licensed to treat adults with moderate to severe ulcerative colitis

The placebo group lost 2.1% of body weight

[DOI] [PubMed] [Google Scholar] Milk D.G., Khong G.C., am O.H., Alfaro-Iraheta F., Tierney C., Kassem F., et al

Saifi et al., 2018